Beta-thalassaemias are a group of hereditary human diseases caused by more that 200 mutations of the human β-globin gene, leading to low or absent production of adult β-globin and an excess of α-globin, causing ineffective erythropoiesis and low or absent production of adult haemoglobin (HbA)1. The conventional treatment for these patients is based on regular blood transfusions and chelating therapy.
Foetal haemoglobin inducers and thalassaemia: novel achievements
GAMBARI, Roberto
2010
Abstract
Beta-thalassaemias are a group of hereditary human diseases caused by more that 200 mutations of the human β-globin gene, leading to low or absent production of adult β-globin and an excess of α-globin, causing ineffective erythropoiesis and low or absent production of adult haemoglobin (HbA)1. The conventional treatment for these patients is based on regular blood transfusions and chelating therapy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
